Wird geladen...
Combined targeting of EGFR and HER2 against prostate cancer stem cells
Progression of prostate cancer has been associated with EGFR and HER2 activation and to tumor-initiating cells contribution toward chemotherapy resistance. We investigated the efficacy of a dual intervention against EGFR and HER2 to deplete the tumor-initiating cells, optimize the chemotherapy manag...
Gespeichert in:
| Veröffentlicht in: | Cancer Biol Ther |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515488/ https://ncbi.nlm.nih.gov/pubmed/32089070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1727702 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|